Literature DB >> 27034250

Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice.

Alexis M Stranahan1, Shuai Hao2, Aditi Dey2, Xiaolin Yu2, Babak Baban3,4.   

Abstract

Accumulating evidence indicates that obesity accelerates the onset of cognitive decline. While mechanisms are still being identified, obesity promotes peripheral inflammation and increases blood-brain barrier (BBB) permeability. However, no studies have manipulated vascular permeability in obesity to determine whether BBB breakdown underlies memory deficits. Protein kinase Cβ (PKCβ) activation destabilizes the BBB, and we used a PKCβ inhibitor (Enzastaurin) to block BBB leakiness in leptin receptor-deficient (db/db) mice. Enzastaurin reversed BBB breakdown in db/db mice and normalized hippocampal function without affecting obesity or metabolism. Flow cytometric analysis of forebrain mononuclear cells (FMCs) from db/db mice revealed macrophage infiltration and induction of the activation marker MHCII in microglia and macrophages. Enzastaurin eliminated macrophage infiltration and MHCII induction, and protein array profiling revealed parallel reductions in IL1β, IL6, MCP1, and TNFα. To investigate whether these signals attract peripheral monocytes, FMCs from Wt and db/db mice were plated below migration inserts containing peritoneal macrophages. Peritoneal macrophages from db/db mice exhibit increases in transmigration that were blocked by recombinant IL1RA. These studies indicate that BBB breakdown impairs cognition in obesity and diabetes by allowing macrophage infiltration, with a potential role for IL1β in trafficking of peripheral monocytes into the brain.
© The Author(s) 2016.

Entities:  

Keywords:  Diabetes; hippocampus; inflammation; learning and memory; microglia; obesity

Mesh:

Substances:

Year:  2016        PMID: 27034250      PMCID: PMC5363667          DOI: 10.1177/0271678X16642233

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  52 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

Review 3.  Neurovascular mechanisms of Alzheimer's neurodegeneration.

Authors:  Berislav V Zlokovic
Journal:  Trends Neurosci       Date:  2005-04       Impact factor: 13.837

4.  Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus.

Authors:  F Asztely; M Kokaia; K Olofsdotter; U Ortegren; O Lindvall
Journal:  Eur J Neurosci       Date:  2000-02       Impact factor: 3.386

5.  The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles.

Authors:  Jörg H W Distler; Astrid Jüngel; Lars C Huber; Christian A Seemayer; Charles F Reich; Renate E Gay; Beat A Michel; Adriano Fontana; Steffen Gay; David S Pisetsky; Oliver Distler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

Review 6.  Lymphocyte roles in metabolic dysfunction: of men and mice.

Authors:  Blanche C Ip; Andrew E Hogan; Barbara S Nikolajczyk
Journal:  Trends Endocrinol Metab       Date:  2015-01-05       Impact factor: 12.015

7.  The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat.

Authors:  Scott E Kanoski; Yanshu Zhang; Wei Zheng; Terry L Davidson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.

Authors:  Nicoletta Ronda; Daniela Greco; Maria Pia Adorni; Francesca Zimetti; Elda Favari; Gunnbjørg Hjeltnes; Knut Mikkelsen; Maria Orietta Borghi; Ennio Giulio Favalli; Rita Gatti; Ivana Hollan; Pier Luigi Meroni; Franco Bernini
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

9.  CCR2 signaling contributes to ischemia-reperfusion injury in kidney.

Authors:  Kengo Furuichi; Takashi Wada; Yasunori Iwata; Kiyoki Kitagawa; Ken-Ichi Kobayashi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Hui Wang; Kouji Matsushima; Motohiro Takeya; William A Kuziel; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

Review 10.  Protein kinase C: poised to signal.

Authors:  Alexandra C Newton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more
  48 in total

1.  Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice.

Authors:  Zhanyang Yu; Li Lin; Yinghua Jiang; Ian Chin; Xiaojie Wang; Xiaokun Li; Eng H Lo; Xiaoying Wang
Journal:  Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.590

2.  Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance.

Authors:  Masaki Yamamoto; De-Huang Guo; Caterina M Hernandez; Alexis M Stranahan
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

Review 3.  White matter and neurological disorders.

Authors:  Han-Gyu Bae; Tai Kyoung Kim; Ho Young Suk; Sangyoung Jung; Dong-Gyu Jo
Journal:  Arch Pharm Res       Date:  2020-09-25       Impact factor: 4.946

Review 4.  The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction.

Authors:  Titikorn Chunchai; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2017-11-21       Impact factor: 3.584

Review 5.  Considering sex differences in the cognitive controls of feeding.

Authors:  Camille H Sample; Terry L Davidson
Journal:  Physiol Behav       Date:  2017-11-22

6.  Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells.

Authors:  De-Huang Guo; Masaki Yamamoto; Caterina M Hernandez; Hesam Khodadadi; Babak Baban; Alexis M Stranahan
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

7.  Lipotoxic Effects of Palmitic Acid on Astrocytes Are Associated with Autophagy Impairment.

Authors:  Ana Ortiz-Rodriguez; Estefania Acaz-Fonseca; Patricia Boya; Maria Angeles Arevalo; Luis M Garcia-Segura
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

8.  Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models.

Authors:  Slava Rom; Viviana Zuluaga-Ramirez; Sachin Gajghate; Alecia Seliga; Malika Winfield; Nathan A Heldt; Mikhail A Kolpakov; Yulia V Bashkirova; Abdel Karim Sabri; Yuri Persidsky
Journal:  Mol Neurobiol       Date:  2018-07-05       Impact factor: 5.590

9.  Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.

Authors:  Xiang Fan; Yinghua Jiang; Zhanyang Yu; Qi Liu; Shuzhen Guo; Xiaochuan Sun; Klaus van Leyen; MingMing Ning; Xiumei Gao; Eng H Lo; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2017-06-04       Impact factor: 6.829

10.  Diabetes Mellitus Impairs White Matter Repair and Long-Term Functional Deficits After Cerebral Ischemia.

Authors:  Shubei Ma; Jianyi Wang; Yanling Wang; Xuejiao Dai; Fei Xu; Xuguang Gao; Joycelyne Johnson; Na Xu; Rehana K Leak; Xiaoming Hu; Yumin Luo; Jun Chen
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.